High population immunity from prior infections and updated vaccines has limited the impact of recent SARS-CoV-2 subvariants such as XFG and BA.3.2, none of which have met World Health Organization criteria for designation as a variant of concern. Genomic surveillance through early 2026 shows steady circulation of these lineages with modest increases in detections, yet overall case rates remain comparable to prior years and no significant rise in severity or immune escape has emerged. This pattern of incremental evolution, combined with effective monitoring and lower public health risk, underpins trader consensus favoring no new variant of concern by the end of 2026.
基於Polymarket數據的AI實驗性摘要。這不是交易建議,也不影響該市場的結算方式。 · 更新於是
$238,975 交易量
$238,975 交易量
是
$238,975 交易量
$238,975 交易量
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
市場開放時間: Dec 1, 2025, 4:49 PM ET
Resolver
0x65070BE91...The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Resolver
0x65070BE91...High population immunity from prior infections and updated vaccines has limited the impact of recent SARS-CoV-2 subvariants such as XFG and BA.3.2, none of which have met World Health Organization criteria for designation as a variant of concern. Genomic surveillance through early 2026 shows steady circulation of these lineages with modest increases in detections, yet overall case rates remain comparable to prior years and no significant rise in severity or immune escape has emerged. This pattern of incremental evolution, combined with effective monitoring and lower public health risk, underpins trader consensus favoring no new variant of concern by the end of 2026.
基於Polymarket數據的AI實驗性摘要。這不是交易建議,也不影響該市場的結算方式。 · 更新於
警惕外部連結哦。
警惕外部連結哦。
Frequently Asked Questions